Panama Issues Medical Cannabis Regs

Home | Canna Law Blog | Panama Issues Medical Cannabis Regs Panama has adopted medical cannabis regulations, after becoming the first Central American country to legalize medical cannabis in October 2021, pursuant to Law 242. The regulations take the form of a decree issued by President Laurentino Cortizo Cohen, which "regulates the use and access to the product and its derivatives, for therapeutic, medical, veterinary, scientific and research purposes throughout the country." The new regulations establish responsibilities for different government agencies, primarily the Health Ministry and the Ministry of Agricultural Development. Import and export activities require approval for the National Directorate of Pharmacies and Drugs. In addition, the decree lists the health conditions for which the use of medical cannabis use may be authorized. Any doctor licensed in Panama can prescribe cannabis, provided they have been certified by the Health Ministry as having received specialized training. The decree also establishes a patient registry. A second decree issued by President Cortizo Cohen establishes the National Directorate for the Monitoring of Activities Related to Medicinal Cannabis (Dirección Nacional para el Monitoreo de las Actividades Relacionadas con el Cannabis Medicinal), which will be under the supervision of Panama's Ministry of Public Safety and draw staff from a number of law enforcement agencies. Among other tasks, the directorate is tasked with establishing "the safety requirements for the handling, transportation, storage and location of the areas and buildings that will be used to manufacture or carry out scientific research on medicinal cannabis." It is also responsible for issuing licenses for medical cannabis production, as well as setting out the security protocols for such activities. With the issuance of regulations, Panama now has a full legal framework in place for medical cannabis. It is hoped that the country's experience will spur further reform in Central America. In fact, less than a year after the signing of Law 242, medical cannabis was legalized in neighboring Costa Rica, where regulations will soon go into effect. Check Out Our Cannabis Law Services Share Twitter Facebook LinkedIn E-mail Comment Fred Rocafort Fred leads Harris Sliwoski’s intellectual property practice and is the coordinator of the firm’s international team. Much of Fred’s practice consists of helping cannabis businesses protect their brands. He also works with entrepreneurs and companies entering the Web3 space, a new frontier for IP law. Prior to joining Harris Sliwoski, Fred worked overseas for more than a decade, in both government and private sector roles. Fred is a regular contributor to the award-winning China Law Blog and Canna Law Blog. Fred began his career overseas as a U.S. consular officer in Guangzhou, China, where he advocated for fairer treatment of American companies and citizens in China and for stronger intellectual property rights enforcement. After entering the private sector, Fred worked at a Shanghai law firm as a foreign legal advisor and later joined one of the oldest American law firms in China, helping foreign companies navigate the Chinese legal environment. He also led the legal team at a Hong Kong-based brand protection consultancy, spending most of his time out in the field, protecting clients against counterfeiters and fraudsters in Greater China, Southeast Asia and Latin America. In addition to his IP work, as a native Spanish speaker, Fred works closely with different Harris Sliwoski teams on Latin America and Spain matters. Fred also provides advice to cannabis industry participants and other businesses on import and export transactions. Fred is an ardent supporter of FC Barcelona—and would be even in the absence of Catalan forebears who immigrated to Puerto Rico in the mid-1800s. Harris Sliwoski Attorney Read more posts [email protected] Read More International Cannabis Law, Medical Marijuana Related Posts September 25, 2026 DEA Enforcement in a Changing Cannabis Landscape: Rescheduling, Hemp, and What Comes Next September 17, 2026 The Supreme Court May Decide if Cannabis-Related Residency Requirements are Unconstitutional September 16, 2026 A $31.8 Million Cannabis-Related Verdict That a Federal Court Wouldn’t Enforce September 15, 2026 Jason Adelstone Moderates Federal Cannabis Policy Discussion at IgniteIt Denver September 11, 2026 Medical Marijuana in Schedule III Survives Its First Major Challenge September 10, 2026 How to Acquire a Colorado Cannabis License September 4, 2026 The Intoxicating Hemp Products Ban Was Delayed a Month. Now What? August 31, 2026 Is the Global Shift to the Right Threatening International Cannabis Reforms? August 28, 2026 Oregon Cannabis Roundup: Fall 2026 August 26, 2026 Five Bills Every California Cannabis Operator Needs to Track in 2026 August 14, 2026 California Cannabis Contracts After Rescheduling: Why Your Contracts Need a Second Look August 4, 2026 DCC License Conversions After Rescheduling: How and When to Split A/M Licenses in California August 3, 2026 The Contradictions of Cannabis Law: From the United States to International Treaties July 28, 2026 What California Operators Must Do After Rescheduling: DEA Registration, License Restructuring, and 280E July 24, 2026 Medical Marijuana Schedule III Litigation: The D.C. Circuit's First Major Test Leave a comment Cancel reply